SECsense Logo

MediWound Ltd. December 2024 Shareholder Meeting Report: Key Vote Insights

$MDWD
Form 6-K
Filed on: 2024-12-19
Source
MediWound Ltd. December 2024 Shareholder Meeting Report: Key Vote Insights

Here are the key insights extracted from the financial report (Form 6-K) of MediWound Ltd. dated December 19, 2024:

  1. Company Information:
  • Name: MediWound Ltd.
  • Address: 42 Hayarkon Street, Yavne, 8122745, Israel.
  • SEC Commission File Number: 001-36349.
  1. Shareholder Meeting:
  • Date of Meeting: December 19, 2024.
  • Presence: 4,049,940 shares represented at the meeting, which is 37.5% of the outstanding ordinary shares.
  • Quorum: The presence constituted a requisite quorum for the meeting.
  1. Proposal Voted:
  • Proposal: Adoption of the Company’s 2024 Share Incentive Plan, which includes rolling over 280,375 ordinary shares from the expiring 2014 Equity Incentive Plan.
  • Voting Results:
    • Votes in Favor: 3,498,317 votes (88%).
    • Votes Against: 477,214 votes (12%).
    • Abstentions: 74,409 votes.
  1. Incorporation by Reference:
  • The report’s content is incorporated by reference into several Registration Statements on Form S-8 and Form F-3 filed with the SEC, dating back to April 2014 and extending to August 2024.
  1. Signature:
  • Date: December 19, 2024.
  • Signed by: Hani Luxenburg, Chief Financial Officer of MediWound Ltd.

This summary highlights the main points regarding the company’s special meeting of shareholders, the voting outcome on the share incentive plan, and relevant legal filings with the SEC.